Epic Research is not viewable using Internet Explorer. Please try accessing it with an alternate browser.
Cosmos Study

Finding the A1c Sweet Spot Lowers Cardiovascular Risk Among Patients with Diabetes

August 5, 2025
Dual-Team Study
Team A:Kersten Bartelt, RNEric Barkley
Team B:Blaine Franklin, PT, DPTGregory Edwards, PhD

Key Findings

  • Diabetic patients with an HbA1c between 7.0 and 7.4% are 13% more likely to experience a novel myocardial infarction (MI) and 8% more likely to experience a novel stroke compared to those with an HbA1c between 6.75 and 6.99%.
  • The likelihood of cardiovascular complications increases with higher average HbA1c levels, up to 153% for MI and 140% for stroke for those with an HbA1c of 10.0% or higher.
  • The likelihood of an MI is reduced by about 10% among patients with an HbA1c between 5.4 and 6.0% compared to those with an HbA1c between 6.75 and 6.99%.

HbA1c is a widely used measure of long-term glucose control in diabetes management. Clinical guidelines typically recommend maintaining HbA1c below 7% for adults with type 2 diabetes to reduce the risk of complications, including cardiovascular events.1

To better understand the relationship between specific HbA1c values and cardiovascular event risk in diabetics, we studied 852,243 patients with type 2 diabetes and no prior history of stroke or MI. Time-weighted average HbA1c levels were tracked for three years starting at least one year post-diagnosis and monitored for evidence of new stroke or MI. We accounted for patient demographics, smoking status, BMI classifications, social vulnerability, and comorbidities in our analysis.

We found that the likelihood of MI rose progressively at higher average HbA1c levels, particularly above 7.0%, as seen in Figure 1. Patients with an average HbA1c between 7.0 and 7.4% were 13% more likely to experience an MI, and those with an average HbA1c of 10.0% or higher were 153% more likely, compared to patients with an average HbA1c between 6.75 and 6.99%. Notably, average HbA1c levels below 5.4% did not confer any additional benefit, with MI risk similar to or higher than for those with an average HbA1c between 6.75 and 6.99%.

Figure 1
Likelihood of MI by Average HbA1c
Likelihood of MI by Average HbA1c
Figure 1. The likelihood of a diabetic patient experiencing an MI or their average HbA1c level.

The pattern for stroke was similar but less steep, with a significant rise beginning at average HbA1c levels above 7.0%. Patients are 140% more likely to have a stroke if their average HbA1c was 10.0% or higher compared to patients with an average HbA1c between 6.75 and 6.99%. The likelihood of stroke was 5% lower among patients with an average HbA1c between 6.1 and 6.4%, while the likelihood was 7% lower for those with an average HbA1c between 5.7 and 6.0%. Notably, average HbA1c levels below 5.7% did not confer any additional benefit, with stroke risk similar to or higher than for those with an average HbA1c between 6.75 and 6.99%.

Figure 2
Likelihood of Stroke by Average HbA1c
Likelihood of Stroke by Average HbA1c
Figure 2. The likelihood of a diabetic patient experiencing a stroke by their average HbA1c level.

These data come from Cosmos, a dataset created in collaboration with a community of Epic health systems representing more than 300 million patient records from 1,700 hospitals and more than 40,000 clinics from all 50 U.S. states, Lebanon, and Saudi Arabia. This study was completed by two teams that worked independently, each composed of a clinician and research scientists. The two teams came to similar conclusions. Graphics by Brian Olson.

References

  1. American Diabetes Association Professional Practice Committee. 6. Glycemic goals and hypoglycemia: Standards of care in diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S111-S125. doi:10.2337/dc24-S006

Data Definitions

Study period
Study population: inclusions
Study population: exclusions
Exposure
Outcomes
Confounders
Race and ethnicity
Model specifications
Stroke
MI
CVD
Family history of CVD
Gestational diabetes
HbA1c
Hyperlipidemia
Hypertension
Face-to-face encounter
Type 2 diabetes